Pursuant to Regulation 29 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Camlin Fine Sciences has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Friday, February 13, 2026, to consider and approve the Un-audited Standalone and Consolidate Financial Results of the Company for the quarter and nine months ended December 31, 2025. Further, the Company has through its letter dated December 23, 2025 intimated regarding the closure of the Trading Window for trading in the Company’s equity shares from January 1, 2026, till the expiry of 48 hours from the date the said financial results are made public.
The above information is a part of company’s filings submitted to BSE.
